Citations for
1ALG3
ALG3 Is a Potential Biomarker for the Prognosis of Bladder Cancer.
Li M, Zhang N, Shan W, Guan B.
Ann Clin Lab Sci. Jan;52(1):117-125 2022
2ALG3, CDG1D
ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings.
Farolfi M, Cechova A, Ondruskova N, Zidkova J, Kousal B, Hansikova H, Honzik T, Liskova P.
BMC Ophthalmol. Jun 5;21(1):249. doi: 10.1186/s12886-021-02013-2. 2021
3ALG3, PPFIA1
Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma
Zhou H, Cao T, Li WP, Wu G.
Mol Biol Rep. Jun;46(3):2693-2701. doi: 10.1007/s11033-019-04712-y. Epub 2019 Feb 25 2019
4ALG3, HSF2
ALG3 Is Activated by Heat Shock Factor 2 and Promotes Breast Cancer Growth.
Yang Y, Zhou Y, Xiong X, Huang M, Ying X, Wang M.
Med Sci Monit. May 25;24:3479-3487. doi: 10.12659/MSM.907461. 2018
5ALG12, ALG3, CDG1A, CDG1B, CDG1D, CDG1G, CDG1J, CDG2B, DPAGT1, MOGS, MPI, PMM2
Mitotic Intragenic Recombination: A Mechanism of Survival for Several Congenital Disorders of Glycosylation.
Kane MS, Davids M, Adams C, Wolfe LA, Cheung HW, Gropman A, Huang Y; NISC Comparative Sequencing Program, Ng BG, Freeze HH, Adams DR, Gahl WA, Boerkoel CF.
Am J Hum Genet 98(2):339-46. doi: 10.1016/j.ajhg.2015.12.007. Epub 2016 Jan 21. 2016
6ALG1, ALG3, ALG6, CDG1C, CDG1D, CDG1K, CDG1U, DPM2
Electroclinical Features of Early-Onset Epileptic Encephalopathies in Congenital Disorders of Glycosylation (CDGs).
Fiumara A, Barone R, Del Campo G, Striano P, Jaeken J.
JIMD Rep IMD Rep. 2015 Oct 10. [Epub ahead of print] 2015
7ALG1, ALG3, ALG6, ALG8, ALG9, B4GALT1, CDG1C, CDG1D, CDG1H, CDG1K, CDG1L, CDG1U, CDG2E, CDG2F, CDG2G, CDG2H, CDG2I, CDG2M, COG1, COG5, COG7, COG8, DPM2, SLC35A2
Congenital disorders of glycosylation with emphasis on cerebellar involvement.
Barone R, Fiumara A, Jaeken J.
Semin Neurol 34(3):357-66. doi: 10.1055/s-0034-1387197. Epub 2014 Sep 5. Review. 2014
8ALG1, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, CDG1A, CDG1B, CDG1C, CDG1D, CDG1E, CDG1F, CDG1G, CDG1H, CDG1I, CDG1J, CDG1K, CDG1L, CDG1N, CDG1O, DK1D, DOLK, DPAGT1, DPM1, DPM3, MPDU1, MPI, PMM2, RFT1
Congenital disorders of glycosylation: An update on defects affecting the biosynthesis of dolichol-linked oligosaccharides.
Haeuptle MA, Hennet T.
Hum Mutat um Mutat. 2009 Oct 27. [Epub ahead of print] 2009
9ALG3, CDG1D
Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.
Rimella-Le-Huu A, Henry H, Kern I, Hanquinet S, Roulet-Perez E, Newman CJ, Superti-Furga A, Bonafé L, Ballhausen D.
J Inherit Metab Dis Inherit Metab Dis. 2008 Aug 9. [Epub ahead of print] 2008
10ALG3,CDG1D
CDG-Id in two siblings with partially different phenotypes.
Kranz C, Sun L, Eklund EA, Krasnewich D, Casey JR, Freeze HH.
Am J Med Genet A 143(13):1414-20. 2007
11ALG1, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, CDG1A, CDG1B, CDG1C, CDG1D, CDG1E, CDG1F, CDG1G, CDG1H, CDG1I, CDG1J, CDG1K, CDG1L, CDG2A, CDG2B, CDG2E, CDG2G, CDG2H, COG1, COG7, COG8, DPAGT1, DPM1, MGAT2, MOGS, MPDU1, MPI, PMM2
Congenital disorders of N-glycosylation including diseases associated with O- as well as N-glycosylation defects.
Leroy JG.
Pediatr Res 60(6):643-56. Epub 2006 Oct 25. 2006
12CDG1D, CDG1E, ALG3
Congenital disorder of glycosylation type Id: clinical phenotype, molecular analysis, prenatal diagnosis, and glycosylation of fetal proteins.
Denecke J, Kranz C, von Kleist-Retzow JCh, Bosse K, Herkenrath P, Debus O, Harms E, Marquardt T.
Pediatr Res 58(2):248-53. Epub 2005 Jul 8. 2005
13CDG1D, ALG3
CDG-Id caused by homozygosity for an ALG3 mutation due to segmental maternal isodisomy UPD3(q21.3-qter).
Schollen E, Grunewald S, Keldermans L, Albrecht B, Korner C, Matthijs G.
Eur J Med Genet 48(2):153-8. Epub 2005 Feb 17. 2005
14ALG3, CDG1D
Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase.
Körner C, Knauer R, Stephani U, Marquardt T, Lehle L, von Figura K.
EMBO J 18(23):6816-22. 1999